Showing 8371-8380 of 20878 results for "".
When it's More than Just Heartburn: Preventing Respiratory Complications of Reflux Disease
https://reachmd.com/programs/primary-care-today/when-its-more-than-just-heartburn-preventing-respiratory-complications-reflux-disease/7893/Respiratory complications of GERD are surprisingly common, particularly in patients experiencing silent, asymptomatic reflux for long periods of time. Yet the frequently subclinical nature of this disease progression is especially difficult to detect. How can clinicians better identify this rising iFrom Institutional to Inspiring Healthcare Design
https://reachmd.com/programs/advances-in-long-term-care-medicine/from-institutional-to-inspiring-healthcare-design/5282/Design of healthcare environments is about more than style and aesthetics. A skillfully-designed hospital room can encourage a patient's healing process, overall well-being and better health outcomes, while reducing stress by creating comfortable surroundings. Much like medicine, healthcare design iHarnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
https://reachmd.com/programs/neurofrontiers/harnessing-neuroplasticity-timing-and-intensity-in-post-stroke-aphasia-intervention/32786/For patients who experience aphasia after a stroke, intervention and social support are crucial for recovery. Dr. Kelly Sloane, Assistant Professor of Neurology at the University of Pennsylvania, highlights how timely therapy and strong support systems can help rebuild both language and confidence iUnderstanding the Complex Link Between PIF, Inhaler Choice, and COPD Outcomes
https://reachmd.com/programs/frontlines-copd/understanding-the-complex-link-between-pif-inhaler-choice-and-copd-outcomes/35545/Since suboptimal peak inspiratory flow (PIF) seems to be associated with a higher risk of hospital readmissions and mortality among patients with COPD, it’s now more important than ever to create a clinically relevant definition. Tune in to hear Dr. Jill Ohar discuss this unmet need as well as the iGlucose Control After Acute Myocardial Infarction
https://reachmd.com/programs/heart-matters/glucose-control-after-acute-myocardial-infarction/5259/Elevated blood sugar levels are quite common among even non-diabetic patients presenting with acute myocardial infarction (or AMI). Does lowering a patient's glucose level actually improve outcomes, and if so, what glucose-control therapies are most effective for these patients? Dr. Mikhail KosiboroPsychological Insulin Resistance
https://reachmd.com/programs/diabetes-discourse/psychological-insulin-resistance/6460/Insulin therapy can be challenging for both the patient with diabetes and their healthcare provider— from needle phobia to weight gain. How can healthcare providers shorten the learning curve to understanding insulin and its benefits? Join host Dr. Steven Edelman and his guest, Dr. Linda Siminerio,The Impact of Race and Ethnicity on Insulin Regimens
https://reachmd.com/programs/diabetes-discourse/the-impact-of-race-and-ethnicity-on-insulin-regimens/6295/The relationship of insulin regimens to race and ethnicity is a new and growing area of research to better understand and provide clinical care at a personalized level. What are significant differences and approaches to these patients' diabetes management? Join host Dr. Steven Edelman and his guest,NICE-SUGAR: Blood Glucose Levels in the ICU
https://reachmd.com/programs/diabetes-discourse/nice-sugar-blood-glucose-levels-in-the-icu/4825/Lowering blood sugar levels in critically ill patients is a widely embraced practice. But according to the results of the NICE-SUGAR study, lowering blood glucose levels in ICU patients may not be safe. Join host Dr. Steven Edelman and his guest, Dr. Irl Hirsch, professor of medicine and the DiabeteNavigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
https://reachmd.com/programs/gi-insights/navigating-gastrointestinal-impacts-of-glp-1-receptor-agonists/35943/GLP-1 receptor agonists are revolutionizing treatment for diabetes and obesity, but their impact on the gastrointestinal tract demands careful clinical attention. Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine at the Mayo Foundation for Medical Education and Research in RocThe Role of Incretins for In-Hospital Management
https://reachmd.com/programs/diabetes-discourse/the-role-of-incretins-for-in-hospital-management/5876/Guidelines that avoid the use of oral antidiabetes agents associated with hypoglycemia and weight gain are becoming increasingly popular in treating patients with diabetes. What are we learning about incretin-based therapies in both the intensive care and emergency medicine departments and periopera